Journal of Pancreatic Cancer

Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma Treated with Combined Modality Treatment Including Surgical Resection: A Pilot Study

Pujan Kandel, Michael B. Wallace, John Stauffer et al. · 2018 · 50 citations · Full text

Medicine, Oncology, Surgery +17

Safety and Pharmacokinetics of CXCR4 Peptide Antagonist, LY2510924, in Combination with Durvalumab in Advanced Refractory Solid Tumors

Mark H. O’Hara, Wells A. Messersmith, Hedy L. Kindler et al. · 2020 · 49 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Euglycemic Diabetic Ketoacidosis Due to Sodium–Glucose Cotransporter 2 Inhibitor Use in Two Patients Undergoing Pancreatectomy

Devon Pace, Katerina Dukleska, S. Phillips et al. · 2018 · 26 citations · Full text

Medicine, Endocrinology, Surgery +17

A Phase I Study of Ribociclib Plus Everolimus in Patients with Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy

Benjamin A. Weinberg, Hongkun Wang, Agnieszka K. Witkiewicz et al. · 2020 · 26 citations · Full text

Medicine, Oncology, Pharmacology +16

Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database

Michael Watson, Jennifer L. Miller-Ocuin, Michael R. Driedger et al. · 2020 · 25 citations · Full text

Medicine, Oncology, Surgery +15